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Available online xxxxAge-related macular degeneration (AMD) is the leading cause of irreversible vision loss. The protein HtrA1 is
enriched in retinal pigment epithelial (RPE) cells isolated from AMD patients and in drusen deposits. However,
it is poorly understood how increased levels of HtrA1 affect the physiological function of the RPE at the intracel-
lular level. Here, we developed hfRPE (human fetal retinal pigment epithelial) cell culturemodelwhere cells fully
differentiated into a polarized functional monolayer. In this model, we ﬁne-tuned the cellular levels of HtrA1 by
targeted overexpression. Our data show that HtrA1 enzymatic activity leads to intracellular degradation of tubu-
lin with a corresponding reduction in the number of microtubules, and consequently to an altered mechanical
cell phenotype. HtrA1 overexpression further leads to impaired apical processes and decreased phagocytosis,
an essential function for photoreceptor survival. These cellular alterations correlate with the AMD phenotype
and thus highlight HtrA1 as an intracellular target for therapeutic interventions towards AMD treatment.
© 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Age-related macular degeneration (AMD) is the leading cause of ir-
reversible vision loss in the elderly population (Coleman et al., 2008).
Although the etiology of AMD still remains elusive, many studies have
resolved that both genetic and environmental factors are involved in
the onset of the disease. Amongothers, oxidative stress, smoking, UV ra-
diation or high fat dietary intake account for the major environmental
risk factors (Clemons et al., 2005; Schick et al., 2016). GWAS studies
have identiﬁed several tightly linked polymorphisms on chromosome
10q26 that are strongly predisposing to AMD and affecting clinicalarija.plodinec@unibas.ch
en access article under the CC BY-NC
rA1 Mediated Intracellular Ef
.12.011outcomes to anti-VEGFA treatments (Fritsche et al., 2014; Fritsche et
al., 2016; Grassmann et al., 2017; Tosi et al., 2017; Yamashiro and
Mori, 2017). In proximity to this genomic locus there are two genes
(ARMS2 and HTRA1) which are the strongest AMD risk loci studied so
far, though it remains contradictory how these genes inﬂuence each
other and which are the causal role in the AMD risk (Cheng et al.,
2013; Friedrich et al., 2015; Grassmann et al., 2017; Ng et al., 2017).
One of these variants is located in the HtrA1 promoter region
(rs11200638) (Dewan et al., 2006; Fritsche et al., 2016; Yang et al.,
2006) and has been strongly suggested to have a putative role in the
AMD pathogenesis. In support of this notion, transgenic mice overex-
pressing HtrA1 in RPE cells recapitulated features associated with ad-
vanced AMD and polypoidal choroidal vasculopathy (PCV) such as:
degradation of the Bruch's membrane, increased damage of the Bruch's
membrane upon exposure to cigarette smoke, and increase of PCV le-
sions (Iejima et al., 2015; Jones et al., 2011; Kumar et al., 2014;
Nakayama et al., 2014; Vierkotten et al., 2011). HtrA1 is a member of-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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contains a homologous active domain to the bacterial serine protease
which is responsible for the proteolytic activity (Eigenbrot et al.,
2012). HtrA1 forms a trimer and its activation is driven by an allosteric
mechanism of inter-monomer communication (Cabrera et al., 2017). It
is also known that conversion by site-directedmutagenesis of the active
domain Ser328 to Alanine (S328A) eliminates the enzymatic activity (Hu
et al., 1998). HtrA1was shown to play an important physiological role in
extracellular matrix homeostasis and to cleave a substantial number of
its components, such as ﬁbronectin, type III collagen, decorin, aggrecan
but also intracellular proteins such as tubulin (Canﬁeld et al., 2007;
Chien et al., 2004; De Luca et al., 2003; Schmidt et al., 2016).The HtrA1
protein has been reported to be present in drusen deposits, a hallmark
of AMD pathogenesis, and within RPE cells isolated from AMD patients,
albeit in a small cohort of patients (Tuo et al., 2008). In our work, we
show clinical data from 10 post-mortem retinas extracted from 5 AMD
patients and 5 healthy subjects that suggest an overexpression of
HtrA1 in AMD and particularly an overexpression in the RPE layer of
AMD patients. Despite different studies which aimed to deﬁne the role
of HtrA1 in human RPE at the molecular level (Saini et al., 2017;
Supanji et al., 2013), it remains to be further investigated how elevated
levels of HtrA1 affect the physiological function of the RPE. This is par-
tially due to the dearth of polarized cell culture models that accurately
preserve the RPE phenotype and which could serve as a relevant cell
model to investigate the consequences of HtrA1 pathological overex-
pression. In this work we have established a highly reproducible RPE
cell culture model where primary hfRPE cells fully differentiated into a
highly polarized and functional monolayer. Using this model and
through an adenovirus mediated overexpression approach, we mimic
the increase of the transcriptional levels associatedwith AMD predispo-
sition and pathogenesis. By direct comparison between the overexpres-
sion of the proteolytically active HtrA1 protein and the enzymatically
inactive S328A variant, which speciﬁcally neutralizes the HtrA1 proteo-
lytic activity and leaves the rest of the protein unaltered, we provide in-
triguing molecular details of the mechanism by which HtrA1 activity
leads to the intracellular degradation of tubulin. We also report the
translation of this phenotype into impaired phagocytosis activity, a
master function of the RPE ensuring photoreceptor survival. These ﬁnd-
ings delineate how induced HtrA1 could be contributing to the etiology
of AMD and provide initial mechanistic insight into the intracellular role
of HtrA1 in RPE cells.2. Materials and Methods
2.1. Human RPE Cell Isolation and Culture
Humanprimary fetal retinal pigmented epithelium(hfRPE) cellswere
purchased fromSciencell (6540). Cells were seeded in transwells (Costar,
3450\3460) previously coatedwith Laminin 521 (BioLamina, LN521–03).
During the ﬁrst week EpiCM 2% FBS (Sciencell, 0010F,) media was
employed to allow for attachment and proliferation (Sciencell, 4101).
At day 4, FBS concentration was decreased to 1%. At day 7, cells were
transferred to a maturation media; a modiﬁcation of the formulation
(MEMAlphamedia (Sigma,M-4526) supplementedwithN1 supplement
at 1% concentration (Sigma, N-6530), Glutamine-Penicillin-Streptomycin
1× (Sigma, G-1146), Non-essential Amino Acid (NEAA,M-7145), Taurine
0.25 mg/mL (Sigma, T-0625), Hydrocortisone 20 μg/L (Sigma, H-03966)
and Triiodo-thyronin 13 ng/L (Sigma, T-5516) previously reported
(Maminishkis et al., 2006; Sonoda et al., 2009). For the apical side of the
transwells we used supplemented media 0.1% Bovine Serum Albumin
(BSA) (Sigma, A-9647). For the basolateral side media with 1% FBS was
employed. Barrier function was evaluated measuring the trans-epithelial
electrical resistance (TER) from 2 wells in 3 independent experiments
after 5 weeks of culture (CellZscope, NanoAnalytics). A mean value of 6
wells and SD was calculated.Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
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To mimic the increase of the HtrA1 transcriptional levels in human
RPE cellswhichhave been associatedwith AMD,weused a recombinant
adenovirus containing the human HTRA1 mRNA (GenBank: NM_
002775; SIRION Biotech) or an enzymatically inactive variant with a
S328A modiﬁcation. After 2 weeks in culture, when the RPE monolayer
was completely established, cells were infected with the recombinant
adenovirus encoding HtrA1, S328A or with a control adenovirus
(Empty Vector). Cells were infected overnight at 37 °C at a multiplicity
of infection (MOI) of 1. The medium was then changed, and the cells
were kept in culture for three more weeks before any experiment was
performed.
For some experiments, a variant from the same constructswasmade
with a HaloTag sequence added in the vector separated from theHTRA1
by a linker sequence. We followed an infection protocol equal to the
above described. Cells were also infected at the second week of growth
and maintained for three more weeks.
2.3. HTRA1 and S328A Interaction Proﬁling by Immuno-Competitive
Capture and Co-Immunoprecipitation
The HTRA1 immuno-competitive capture was performed as previ-
ously described (Meistermann et al., 2014). A commercial anti- HTRA1
antibody was used for IP and competition experiments (MAB2916,
R&D, RRID:AB_212271) and western blot detection was performed
with an in-house anti-HTRA1 antibody (Vierkotten et al., 2011). Anti-
tubulin (MAB3408, RRID:AB 94650) was used for IP and (Ab52623,
RRID:AB_869991) for blot detection. RPE lysate from overexpressing
HTRA1 and S328A cells (500 μg total protein per condition)were pre-in-
cubated for 1 h with increasing concentrations of free anti-HTRA1 anti-
body (0, 1, 2.5, 5 and 10 μg/mL) in triplicates.
Pre-incubated lysates were then loaded on a resin with immobilized
anti-HTRA1 and incubated for 1 h. Eluateswere separated on SDS-PAGE
in three bands spanning from 20 to 120 kDa followed by in-gel trypsin.
Samples were analyzed with a nanoﬂow Easy-nLC system (Proxeon)
connected to an Orbitrap Fusion Tribrid mass spectrometer (Thermo
Fisher Scientiﬁc). Raw ﬁles were then processed with Progenesis QI
for proteomics (Nonlinear Dynamics) and searches were conducted
with Mascot against a concatenated forward/reverse human database
allowing for a spectrum false-discovery rate of 1%. Statistical analyses
were performed in R as previously described (Meistermann et al.,
2014). Brieﬂy, after data quality control of identiﬁed peptide peaks,
log2 scaled extracted ion counts (XIC) were normalized and summa-
rized to relative protein abundance. To identify proteins displaced
with increasing concentration of free anti-HTRA1 antibody, a linear
model was ﬁt using a set of contrasts (Augustin et al., 2013). The con-
trasts compare the protein abundance values above and below each
concentration point. Then the maximum of the contrasts moderated t-
statistics (Smyth, 2004) was obtained for each protein. Multiple testing
adjusted signiﬁcance (p-values) was derived by permutation testing.
2.4. Western Blotting
Cells werewashedwith PBS and lysedwith RIPA buffer (Thermo Sci-
entiﬁc) containing protease inhibitors (Roche Diagnostics GmbH,
Mannheim, Germany). 200 μL cell media was precipitated with ice
cold acetone at least 1 h at −20 °C and then centrifuged at 16,000g
for 10 min. Cell pellet proteins were then dissolved with RIPA buffer
containing anti-protease. Samples (25 μg per cells, 20 μL per media)
were then denatured in NuPage® LDS Sample buffer 4× (Invitrogen,
UK) at 70 °C for 10 min and run on commercially produced pre-cast
4–15% Criterion TGX Strain-Free gels (Bio\\Rad) with Tris/Glycine/
SDS (TGS) buffer (Bio\\Rad). The proteins were transferred to a
Trans-Blot® Turbo™ (Bio\\Rad) membrane using the Trans-Blot®
Turbo™ Transfer System (Bio\\Rad) for 7 min. Membranes werefects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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in Tris-buffered saline (TBS) (Sigma)+ 0.05% Tween-20 (Sigma) for 1 h
at RT prior to incubation with primary antibodies speciﬁc to Tubulin
(1:250, MAB3408; Millipore, RRID:AB_94650), HtrA1 (1:1000,
(Vierkotten et al., 2011), Serpin F1/PEDF (1:250, AF1177, R&D Systems,
RRID:AB_2187173), E-Cadherin (1:500, 610,182, BD Transduction Labo-
ratories™, RRID:AB_39758), C1QTNF5 (1:250, MAB3167, R&D Systems,
RRID:AB_2065810) with TBP (1:250, ab51841, Abcam, RRID:AB_
945758) as the loading control, overnight at 4 °C. Immunodetection
was performed by incubating the membranes with secondary antibod-
ies IRDye®680CWdonkey anti-rabbit IgG (H+L), IRDye®800CWdon-
key anti-mouse IgG (H+ L), and/or donkey anti-goat (H+ L) (1:5000,
LI-COR Bioscience, Lincoln, NE) for 1 h at RT prior to washing with TBS
+ 0.05% Tween-20. Immunoreactive bands were visualized using the
LI-COR Odyssey® infrared imaging system (LI-COR Bioscience, Lincoln,
NE) according to the manufacturer's speciﬁcations.
2.5. Total RNA Preparation
Quadruplicate cell samples per time point (day 7, 14, 21, 28, 35)
were available. After cell lysis and total RNA extraction in phenol/chlo-
roform, the aqueous phase was processed using the RNeasy® Mini Kit
(QIAGEN) as per the manufacturer's instructions. The quantity and
quality of total RNA sampleswere assessed by spectrophotometric anal-
ysis (Thermo Scientiﬁc Qubit® 3.0 ﬂuorometer) and by proﬁling on an
Agilent Tapestation® 2200. The minimal sample amount was 1.61 μg
with an average amount of 3.45 μg. The minimal RNA integrity number
was 8.3 with an average of 9.52. Total RNA samples were normalized at
a concentration of 80 ng/μL.
2.6. mRNA Sequencing
100 ng input total RNA per sample were converted into cDNA librar-
ies following the Illumina TruSeq® stranded total RNA sample prepara-
tion protocol with Ribo Zero Gold (cat RS-122-2301). The total RNA,
once depleted from cytoplasmic and mitochondrial ribosomal RNA,
was fragmented and converted into double-stranded cDNA. Single-
stranded adaptors that include unique barcode sequences were at-
tached via ligation. The resultingmoleculeswere ampliﬁed via polymer-
ase chain reaction. The fragment size distribution of each library was
quality-controlled using the Agilent Tapestation® 2200. The cDNA frag-
ment size ranged 266–304 bp with an average of 280 bp. Libraries were
quantiﬁed based on triplicate reactions of the Kapa® library quantiﬁca-
tion kit (Kapa Biosystems®, cat KK4835) using serial dilutions down to
1:8000. The concentrations ranged 11–98 nMwith an average of 49 nM.
The 20 libraries were normalized to 2 nM and pooled by 6 (including
unrelated libraries) for each ﬂow cell lane, as per the randomization
plan. The pooled libraries were spiked in with 10% PhiX library and
were bound to the surface of the ﬂow cells at equimolar amounts of
11 picoM. Each template molecule was clonally ampliﬁed using a
Cbot2® system (Illumina). Sequencing by synthesis was performed on
the Illumina HiSeq2500®, using a strategy of 2x50bp paired-end se-
quencing. The total read depth ranged 16.8–27.3million reads per sam-
ple mapped to the February 2009 human reference sequence hg19
(https://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19), with an
average of 22.3 million mapped reads.
2.7. miRNA Sequencing
1 μg total RNA of every sample was processed following the Illumina
TruSeq small RNAseq library prep protocol (cat. RS-200-0012–0024). A
single stranded 3’-RNA adapter and a single stranded 5’-RNA adapter
were ligated to the total RNA of all samples. After reverse transcription,
PCR-ampliﬁcation of the resulting cDNA was performed using a unique
primer pair for each sample. Each library was quantiﬁed before gel-
puriﬁcation based on Kapa® quantiﬁcation (Kapa Biosystems®, catPlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
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ranged 1.3–2.9 μg cDNAwith an average of 2.1 μg. The fragment size dis-
tribution of each library was quality-controlled using the Agilent
Tapestation® 2200. The 20 libraries were pooled and electrophoresed
on a 10% acrylamide gel for puriﬁcation of fragments spanning 140–
160 base pairs. This fragment size covers the adaptor-ligated mature
miRNAs, where the adaptors account for 120 bp. The content of this
extract was quality-controlled using the Agilent Tapestation® 2200.
The average library size was 150 bp. The concentration was determined
with the Kapa® library quantiﬁcation kit (Kapa Biosystems®, cat
KK4835) using 3 independent 10−6 dilutions of the gel-puriﬁed library
pool. The concentration was normalized to 2 nM, spiked in with 10%
PhiX library and loaded onto two ﬂow cell lanes of a rapid HiSeq2500
run at a concentration of 13 pM. Each template molecule was clonally
ampliﬁed using a Cbot2® system (Illumina). Sequencing by synthesis
was performed on the Illumina HiSeq2500®, using a strategy of 50 bp
single-end. The total read depth ranged 4.5–13.3million reads per sam-
ple mapped to the February 2009 human reference sequence hg19
(https://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19), with an
average of 8.4 million reads.
2.8. Sequence Analysis
For mRNA and miRNA sequencing, the data were demultiplexed
using Illlumina's CASAVA software, which converts the base call ﬁles
into Fastq-ﬁles and simultaneously sorts the Fastq-ﬁles based on
barcode information. Read depth per sample, sequence length distribu-
tion, Phred quality score, detection of duplicate sequences, GC content,
distributions of base quality and base frequency per sample, were con-
trolled before reads' mapping onto the human reference genome.
2.9. mRNA Sequencing Data Analysis
In order to estimate gene expression levels, paired-end RNAseq
reads were mapped to the human genome (hg19) by using the short-
read aligner GSNAP (Wu and Nacu, 2010; Wu and Watanabe, 2005).
The number of mapped reads for all RefSeq transcript variants of a
gene (counts) were combined into a single value by using SAMTOOLS
software (Li et al., 2012) and normalized denoted as rpkms (number
of mapped reads per kilobase transcript per million sequenced reads,
(Mortazavi et al., 2008).
2.10. Micro RNA Sequencing Data Analysis
Adapter trimming on the raw micro-RNA sequence reads allowing
up to one mismatch was performed by sRNABench (Barturen et al.,
2014). Trimmed sequence reads of length 15 bp or more were then
mapped onto hg19 including known micro RNAs (Grifﬁths-Jones,
2003) frommiRBaswith Bowtie (Langmead et al., 2009) using “genome
mode” of sRNABench. Read counts and normalized reads counts per
miRBase and novel micro-RNAs were generated by sRNABench.
2.11. Immunocytochemistry
Cells were ﬁxed in 4% paraformaldehyde at room temperature,
washed and permeabilized. Incubated primary antibodies were:
Tubulin (1:500, MAB3408, Millipore, RRID:AB_94650), HtrA1 (1:500)
(Vierkotten et al., 2011), α-acetylated Tubulin(1:500, T6793, Sigma,
RRID:AB_477585), α-acetylated-Tubulin (1:800, 5535P, Cell Signaling
Technology, RRID:AB_10548757) Serpin F1/PEDF (1:200, AF1177, R&D
Systems, RRID:AB_2187173), E-Cadherin (1:200, 610,182, BD Transduc-
tion Laboratories, RRID:AB_397581), N-Cadherin (1:200, NBP1-48309,
Novus Biologicals, RRID:AB_10011059), Claudin 19 (1:100, sc-162,687,
Santa Cruz Biotechnology, RRID:AB_10918628) and Occludin (1:200,
331,500, LifeTechnologies, RRID:AB_2533101), Anti-Na+/K+ ATPase
alpha-1, clone C464.6 (1:500, Millipore, 05–369, RRID:AB_309699).fects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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647 or Cy3 coupled antibodies (1:200, Jackson) and DAPI was added
to the samples (LifeTechnologies). Samples were mounted with non-
hardening mounting medium (H-1000, Vector Shield).
2.12. Procurement of Retina Tissue and IHC Staining and Imaging
2.12.1. Post-Mortem Retinal Tissue Samples Were Donated by Eugenda
(Uni Koeln)
Criteria for patient classiﬁcation were absence of disorders of choroid
and retina for the control patients (referred in the text as healthy subject)
or a conﬁrmed diagnosis of dry AMDby Eye care professional (refereed in
the text as AMD patient). Sections of 4 μm thickness were obtained from
formalin-ﬁxed, parafﬁn-embedded human eye tissue from 5 healthy do-
nors and 5 AMD patients. An immunohistochemestry (IHC) staining pro-
tocol was performed with the automated IHC research slide staining
system Ventana Discovery Ultra. Stainings were carried out utilizing pro-
tocols and reagents according to the instructions of themanufacturer. An
anti- HtrA1 (1:500) (Vierkotten et al., 2011) was employed as a primary
antibody. A secondary antibody anti-rabbit HRP conjugated antibody
(VENTANA, 760-4311)was used to detect the primary antibody. As chro-
mogen, the Discovery Purple Kit (VENTANA, 760-229) was employed.
Nuclear counterstaining was performed with hematoxylin.
An Olympus system VS120 slide scanner with a dry 40× objective
was employed to acquire the images of the stained retinas.
2.13. Imaging and Analysis
Unless otherwise stated, the general protocol to image the samples
was done employing a laser scanning confocal microscope Zeiss 710
with a 40× (tile scan images in Fig. 5) or 63× water immersion objec-
tive. For high resolution images (Fig. 3B), stacks were acquired every
130 nm and imageswere then deconvolved (Scientiﬁc Volume Imaging,
Huygens) and plotted with Imaris (Bitplane Scientiﬁc).
Apical imaging of the living RPE cells (Figs. 5 and 6) was performed
using an upright microscope (LSI, Leica) equipped with a water immer-
sion lens 63× maintained at 37 °C and 5%CO2 conditions. Orthogonal
views and 3D images were generated with the same software used for
the acquisition.
2.14. Intracellular β-Tubulin Quantiﬁcation
Intracellular RPE tubulin intensity was measured in cells overex-
pressing HTRA1. At least 9 images/experiment were acquired using
the same acquisition parameters (3 independent experiments). Images
were evaluated using Image J software analysis. A region of interest was
drawn on the surface occupied by at least 14 HTRA1 positive cells/
image.We analyzed ≥400 cells per condition. Amean intensity per con-
dition was calculated with all ROIs on the β-tubulin channel staining.
2.15. Transmission Electron Microscopy
Samples prepared for the TEM were ﬁrst ﬁxed during 24 h at 4 °C
with a ﬁxative solution containing 2%PFA, 2.5% glutaraldehyde in
0.1 M phosphate buffer (pH 7.4). Samples were then washed in 0.1 M
cacodylate (pH 7.4). Transwell membranes were removed from the
inserts and with the aid of a scalpel; small squares (5x5mm) were cut.
A post-ﬁxation step was done with 2% Osmium tetroxide in 0.1 M
cacodylat buffer pH 7.4 for 2 h at room temperature followed by a
rinsewith cacodylate buffer at pH7.4. After dehydration steps in graded
acetone series the membranes were ﬂat-embedded in Epon812. Resin
polymerization was performed overnight at 60 °C. After trimming the
block, ultra-thin sections (90 nm thickness) were donewith a diamond
knife on an ultramicrotome (Reichert Ultracut S) and collected on 200
mesh Nickel grids. A ﬁnal step was performed staining with 5% UranylPlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
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1010 transmission electron microscope.
For the immunogold detection of HtrA1, cellswere ﬁxed for 24 h in 1%
PFA in 0.1 M phosphate buffer at 4 °C. Transwell membranes were re-
moved from the inserts and with the aid of a scalpel; small squares
(5x5mm) were cut. These pieces were then incubated overnight in a
2.3 M sucrose solution. The small squares were subsequently embedded
in 12% gelatin. Sections 100 nm thick were cut at−120 °C and collected
in a mixture of 1:1 2.3 M sucrose/2% methylcellulose. Labeling was per-
formed on the sections, as described previously (Slot et al., 1991). Images
of the samples were acquired on a JEOL 1010 transmission electron
microscope.
For microvilli quantiﬁcation 10 cells per condition were quantiﬁed,
as well as the length of the membrane. The number of microvilli per
cell was normalized for the μm pf plasma membrane. A Wilcoxon
Mann Whitney test was performed to assess for signiﬁcance in the dif-
ference between S328A and HtrA1 overexpressing cells.
2.16. Scanning Electron Microscopy
Samples for SEMwere prepared using standard procedureswith ﬁx-
ation using 2.5% glutaraldehyde and 2.5% paraformaldehyde in 0.1 M
cacodylate buffer pH 7.4 (11,650, Electron Microscopy Sciences) for
1 h at room temperature, then rinsing in cacodylate buffer 0.1 M
pH 7.4, and dehydration in an ethanol gradient. Samples were further
dehydrated in ethanol gradient, critical point dryed (Critical Point
Dryer- Tousimis Autosamdri 815), then sputter coated with 20 nm
gold (Leica EM ACE600-Doube Sputter Coater) and analyzed using a
SEM - FEI Nova Nano SEM230 or SEM - FEI Helios Nano Lab 650.
2.17. Atomic Force Microscopy (AFM)
All AFM experiments were carried out under close to physiological
conditions using a customized mechano-optical microscope (MOM)
comprised of an AFM (JPK Instruments AG, Germany and SPECS Zurich
GmbH, Switzerland) and epiﬂuorescence/spinning disk confocal setup
(Visitron Systems GmbH, Germany). Bright ﬁeld and ﬂuorescence im-
ages were taken with 40 and 63 x oil immersion objectives (Leica, Ger-
many) and recorded using an ORCA Flash 4 sCMOS (Hamamatsu
Photonics K.K., Japan). For AFM experiments standard rectangular HQ-
CSC38/CR-AU B cantilevers with a nominal spring constant of
0.03N/mand a nominal tip radius of 20 nm(NanoAndMoreGmbH, Ger-
many) were used. The experimental value for the spring constant of
each cantilever was determined by thermal tune method. For cell stiff-
ness measurements, the AFM was operated in “Force-Volume Mode”.
Brieﬂy, arrays of force–displacement curves were recorded in a regular
grid over a selected sample surface of 80 × 80 μm. Each of the 4096
(64 × 64) force–displacement curves per sample was sampled with
20 kHz. All indentations were performed with the maximum load set
to 1.8 nN at an indentation velocity of 16 μm/s. Individual AFM stiffness
mapwas completedwithin 45min. For time-lapse and S328A/HtrA1 ex-
pression experiments, RPE cells were cultured on hanging insert mem-
branes. For MOM experiments, the membranes were cut off from the
insert and ﬂat mounted onto an 18-mm coverslip. The coverslip was
then inserted into a custom-made sample holder, which enabled correl-
ative AFM and confocal measurements. To align optical and AFM mea-
surements, bright-ﬁeld and confocal images were recorded as z-stacks
prior to each AFM measurement while the cantilever was contacting
the sample surface, at the center of the AFM forcemap. During themea-
surements, culture dishes were replenished with fresh buffered DFCS
saturated with 5% CO2 to maintain physiological conditions and com-
pensate for evaporation. Post-AFM, RPE cells were ﬁxed for further im-
munoﬂuorescence analysis. AFM data were further analyzed using the
custom-made “OfﬂineReader”, OriginPro 2016 (OriginLab Corporation,
USA) as described previously (Plodinec et al., 2012) and Gwyddion
(http://gwyddion.net/) software. The optical images were analyzedfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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bin width of 7.5 Pa, mean-values and standard deviations were extract-
ed from Gaussian ﬁts onto the raw data. Statistical analysis was per-
formed using two-sample student's t-test. Statistical signiﬁcance was
tested at p= 0.05.2.18. Halotag Visualization and Tubulin Life Staining
To visualize the protease within the HaloTag-HTRA1 and HaloTag-
S328A overexpressing cells we performed a rapid labelling protocol ac-
cording to themanufacturer's instructions (Promega). Brieﬂy, cellswere
incubated with the Halotag TMR ligand (G8251, Promega) at a concen-
tration 5 μMduring 30min at 37 °C, washed twice with freshmedia, in-
cubated again for 30 min at 37 °C with fresh media and imaged using
phenol red free fresh MEM (41,061, Gibco).
To stain for tubulin in living cells, samples were incubated for 6 h at
37 °C with SiR-Tubulin at a concentration of 200 nM (SC006,
Spirichrome). Cells were thenwashed twicewith freshmedia and incu-
bated with the Halotag ligand following the protocol previously de-
scribed. Prior to imaging, cells were stained with Hoechst following
the manufacturer's speciﬁcations (33,342, Lifetechnologies).2.19. Cilia Quantiﬁcation
RPE cells overexpressing HTRA1 or S328Awere ﬁxed and stained for
tubulin. At least 9 images in 3 independent wells were acquired in con-
focal microscope with a 63× water immersion lens. Images were then
analyzed by Image J software. Maximum intensity projections from
the z-stacks were generated and cells with at least 3 cilia were counted,
as well as total cells (DAPI). ≥4000 cells were analyzed per condition
and the percentage of ciliated population was calculated.2.20. Phagocytic Challenge
Differentiated RPE cells were challenged with pHRodo-labelled red
Zymosan bioparticles 100 μg/mL (Invitrogen, P35364) during 5 h. Sam-
ples were washed and stained with Hoechst (33,342, Lifetechnologies).
Phagocytic activity was inhibited by Cytochalasyn D 0.2 μM (Sigma,
C8273). Six images from 2wells\experimentwere acquired (3 indepen-
dent experiments were conducted). Stacks were analyzed with Imaris
software (Bitplane Scientiﬁc). Images were ﬁrst subjected to a back-
ground substraction and then processed with the Spots module from
Imaris. Particles of an estimated spot diameter of 800 nmwere detected
automatically and ﬁltered based on a minimum satisfying intensity.
Values higher than the set threshold were considered for analyses. Ap-
propriate threshold values were conﬁrmed by visual inspection of cor-
rect particle detection. Phagocytic activity was expressed as a
percentage of the maximum activity, or that of the control cells.2.21. POS Assay
Photoreceptor outer segments (POS) were isolated from freshly
slaughtered porcine eyes as described (Schraermeyer et al., 1997). Iso-
lated retinae were agitated for 2 min in KCl sucrose buffer and centri-
fuged at 7 k rpm for 5 min. Isolated POS were washed and labelled
with CY5 Maleimide Mono-Reactive Dye (PA25031 Amersham GE
Healthcare). Cells were incubated for 6 h at 37 °Cwithmedia containing
labelled POS. Cultures were washed with PBS and immediately ﬁxed.
Nuclei were stained with Hoechst dye (33,342, Invitrogen). POS uptake
was visualized by confocal microscopy (Zeiss LSM710; Carl Zeiss AG,
Feldbach, Switzerland) ≥10 images\experiment; cells containing at
least 3 particles where considered to be positive. Mean and SD were
calculated from 2 independent experiments.Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.0112.22. Terminal Amine Isotopic Labeling of Substrate (TAILS)
In order to ﬁnd the potential intracellular proteins that could be
regulated by HtrA1 activity, we performed a different approach: we
inhibited the endogenous levels of this protease in control cells (not
overexpressing any protein) with two HtrA1 serine protease inhibitors
(Compound RI2404: N-[(2S)-3-(3-chlorophenyl)-1-[[(1S)-2-[[(3S)-
5,5-diﬂuoro-2-methyl-4,6-dioxo-6-(2,2,2-triﬂuoroethylamino)hexan-
3-yl]amino]-1-(4-methoxyphenyl)-2-oxoethyl]amino]-1-oxopropan-
2-yl]pyridine-2-carboxamide and Compound EM3770: N-[(2S)-3-(3-
cyanophenyl)-1-[[(1S)-2-[[(3S)-5,5-diﬂuoro-2-methyl-4,6-dioxo-6-
(2,2,2-triﬂuoroethylamino)hexan-3-yl]amino]-1-(4-methoxyphenyl)-
2-oxoethyl]amino]-1-oxopropan-2-yl]pyridine-2-carboxamide). Brief-
ly, cells were grown following the described protocol and at day 35
media was replaced by serum free media containing the compounds
at a concentration of 10 μM in 0.2% DMSO. Control cells, not containing
any inhibitor were also treated with the same media containing 0.2%
DMSO. Four days later, RPE cell lysates were harvested using 3 M
guanidinium chloride plus protease inhibitors (1 μM E64, 5 mM EDTA
and 1 mM PMSF) followed by centrifugation at 13,000 rpm for 10 min
at 4 °C and TAILS was performed as described previously. Protein con-
centration was determined using bicinchonic acid assay. 0.5 mg of pro-
teins per condition were labelled with either medium formaldehyde
(12CD2O), sodium cyanoborodeuteride (NaBH3CN) or heavy formalde-
hyde (13CD2O), sodium cyanoborodeuteride (NaBD3CN) and then
mixed in a 1:1 ratio. After tryptic digestion, internal peptides were cap-
tured by an amine-reactive polymer, whereas blocked N-terminal pep-
tides were collected by ultraﬁltration and desalted using reverse-phase
C18 column. The sample was pre-fractionated by strong cation ex-
change chromatography and applied to liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis. LC-MS/MS data was acquired
using the Q-Exactive plus system as described previously
(Koczorowska et al., 2016). Data analysis and relative peptide quantita-
tion was performed as described previously (Koczorowska et al., 2016)
with the exception of lysine and N-terminal di-methylation (medium
formaldehyde +32.05 Da; heavy formaldehyde +36.07 Da).
2.23. In vitro Microtubule Polymerization and HTRA1 Digestion
Hylite 488 ﬂuorescent labelled microtubules (TL488M, Cytoskele-
ton)were polymerized following the instructions provided by theman-
ufacturer. In brief, monomers of the microtubules were polymerized in
5 μL of GPEM buffer 10% Glycerol (Cytoskeleton, BST01, BST05, BT06) at
37 °C during 20 min. The polymerized microtubules were then resus-
pended inwarmGPEMbuffer 30% glycerol. HtrA1 recombinant proteins
(Origene, TP322362) and S328A (Origene, TP700208) were added to a
ﬁnal concentration of 10 μg/mL. As a control for microtubule stabiliza-
tion,we added Paclitaxel (Cytoskeleton, TXD01) to a ﬁnal concentration
of 20 μM. For each condition two replicates of 50 μL were generated and
kept at 37 °C. Samples for observation were prepared by pipetting two
microliters from each sample and mounting them between a slide and
a coverslip. Five images from each well were taken at time points
5 min (just after adding the proteases), 6 h and 24 h. Images were ac-
quired in a microscope (Zeiss, Observer Z.1) coupled to a ﬂuorescence
lamp and a camera (Insight, Spot 2Mpixel) using a 63× water immer-
sion objective. Images were analyzed with ImageJ using the tubeness
plugin for tube-like structure detection. The analysis performs a gauss-
ian convolution using a user deﬁned sigma value that depends on the
thickness of the tubes. A sigma value of 0.003 was selected as it pro-
duced the best results for our images in terms of polymers detection.
The analyze particle pluginwas used, providing a tablewith the number
of objects found and their area. Values from each conditionwere plotted
together in Graphpad as a histogram using a Bin Center of 0.5 μm2. This
enabled us to obtain distribution of themicrotubule size population and
calculate the percentage occurring for a deﬁned range of surface. We
considered two have three types of events in our samples: smallfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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count for segments of depolymerized microtubules, middle microtu-
bules (area 0.75–3.25 μm2, bin center 1–3) and long microtubules
(area ≥ 3.5 μm2, bin center ≥3.5). Statistical analyses were performed
also in GraphPad Prism using a Mann-Whitney non-parametric test
for two groups to compare samples treated with HTRA1 wild type pro-
tease or S328A HTRA1.
2.24. In vitro Microtubule Polymerization
An in vitro tubulin polymerization assay (BK006P, Cytoskeleton) was
performed following the manufacturer's instructions. Brieﬂy, a solution
of tubulin monomers (2 mg/mL) was prepared and kept on ice using G-
PEM buffer (80 mM PIPES, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, 1 mM
GTP). Recombinant HTRA1 (Origene, TP322362) and HTRA1(S328A)
(Origene, TP700208) were added to a ﬁnal concentration of 10 μg/mL.
Sampleswere then incubated for 30min at 4 °C. Paclitaxel at a concentra-
tion of 10 μMwas added in all conditions as a positive control. After incu-
bation, sampleswere transferred to awarmplate andpolymerizationwas
monitored by absorbance at 340 nm during the following 90 min and
keeping the plate reader at 37 °C. For each experimental condition, the
signals from three independent replicates were averaged. Each signal
was ﬁtted by the sigmoid function with three free parameters
tð Þ ¼ Srel
1
1þ eð−k F t−t0ð Þ 
where kF is the growth rate constant and t0 is the position of the inﬂection
point of the curve and Srel a relative signal amplitude. The latter was nor-
malized to 1 corresponding to the largest occurring value among all con-
ditions. The nucleation time point (tlag) is deﬁned as the point when the
tangent passing for the inﬂection crosses the time axis. It follows from
the above parameters as:
tlag ¼ t0−
Srel
2kF
3. Results
3.1. Clinical Evidence of an Increased HtrA1 Content in AMD Patients
To investigate the functional signiﬁcance and tissue localization of
the HtrA1 protein in human retinas form healthy subjects and AMD
patients, we used Immunohistochemistry to re-conﬁrm that HTRA1 is
expressed intracellularly in the RPE layer and in the BM (Figs. 1A and
S1) (Yang et al., 2006). The expression levels of the HtrA1 protein ap-
peared higher in those samples corresponding to the AMD group, as
seen by a stronger immunohistochemical HtrA1 staining and correlated
with AMD-related structural changes in the retinal pigment epithelium
(Bonilha, 2008). The RPE layer in the AMD patients presents a number
of structural changes including: depigmentation due to the loss of mel-
anin granules, disorganization of the basal infoldings, increase in the ac-
cumulation of basal deposits on or within Bruch's membrane, presence
of drusen (between the basal lamina of the RPE and the inner collage-
nous layer of Bruch's membrane) and thickening of Bruch's membrane
(Figs. 1A and S1). Unfortunately, our analysis of human retina tissues
is limited to only 5 AMD patients' eyes and to 5 healthy subject eyes.
However, these results represent an important base to further investi-
gate the basic mechanisms induced by intracellular HtrA1 pathological
overexpression andhighlight the importance to develop a humanpolar-
ized adult-like RPE model resembling the RPE layer in the retina tissue.Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.0113.2. Characterization of a Human Polarized Adult-like RPE Cellular Model
Before investigating how increased levels of HtrA1 affect RPE func-
tionality, we considered how to best employ RPE in our study. The pu-
tative role of HtrA1 in AMD pathophysiology has been associated with
polarized and adult RPE, which have deﬁned structural, molecular,
and apical and basolateral polarized functionalities (Lehmann et al.,
2014). We hypothesized that promoting RPE polarization features
would represent a more physiological cellular model to investigate, at
the molecular level, the consequences induced by HtrA1 pathological
overexpression. In order to achieve a robust and reproducible cellular
model, primary hfRPE were grown in PET transwell inserts following a
protocol that involves conceptually three steps: adhesion; expansion
and maturation (Fig. 1B). Maturation is promoted by using inserts pre-
viously coated with laminin 521, which is a major component of the
Bruch's membrane and has been reported to effectively support the dif-
ferentiation of pluripotent stem cells into RPE cells (Plaza Reyes et al.,
2016). Moreover further optimization of the maturation medium was
established by adapting a previously described RPE differentiation me-
dium (Maminishkis et al., 2006; Sonoda et al., 2009).
To validate our protocol, we analyzed gene expression patterns at
days 7, 14, 21, 28 and 35. Genes associated with the RPE signature
could be divided in three clusters: genes increased during maturation
(Fig. 1C), genes with consistently high expression (Fig. S1b, left),
genes with consistently low expression (Fig. S1b, right). Interestingly,
we could observe a drastic difference in the gene expression between
days 7 and 14, coinciding with the switch to the maturation media.
The genes increased during maturation and genes with consistently
high expression include adult RPE markers such as: solute carriers
(SLC16A8, SLC39A12, SLC6A15 or SLC4A5), genes related to the regener-
ation of visual pigments and completion of the visual cycle (LRAT,
RDH5, RDH 11, RLBP1, CRX), genes associated with cell-cell and cell ma-
trix adhesion (CDH3, ITGB8 and COL9A3), and well known RPE markers
(BEST1, SERPINF1, RPE65, RBP1, TIMP3, ADAM9 or VEGFA). Interestingly,
many of these genes were also identiﬁed and reported for hfRPE cells
in a former transcriptomic analysis where different RPE types (fetal/
adult and native/cultured) were compared (Strunnikova et al., 2010).
We also proﬁled the miRNA expression pattern at different time
points and identiﬁed 7 miRNA (supplemental table S1) reported to be
present in mouse and human RPE cells of different origin: RPE cells de-
rived from either induced pluripotent stem cells (iPS) or embryonic
stem cells (ESC) and primary RPE isolated from retina tissue. From the
7 dentiﬁed miRNA, 2 of them were also present in RPE from mouse:
hsa-miR-30a-5p and hsa-miR-181a-5p (Ohana et al., 2015; Soundara
Pandi et al., 2013). Two more miRNA matched proﬁles found in mouse
and also human: hsa-miR-204-5p (Li et al., 2012; Ohana et al., 2015;
Soundara Pandi et al., 2013) and hsa-miR-99b-5p (Soundara Pandi et
al., 2013; Wang et al., 2014). A total of 3 miRNA were only reported to
be present in human iPS-derived RPE cells: hsa-miR-27a-3p, hsa-miR-
100-5p and hsa-miR-23b-3p (Wang et al., 2014). Together, these results
suggest that the maturation step shifts the gene-expression proﬁle of
primary human RPE towards an adult-like pattern.
Characterization of the RPE phenotype at the end of the maturation
was performed by several means. Polarization and an RPE signature
could be conﬁrmed by the immunostaining of several markers, such as
Na+K+ ATPase, Claudin 19, Occludin, E-cadherin, N-cadherin and PEDF
(Figs. 1D and S1f). As well, we could conﬁrm the characteristic epithelial
polarizationwith clearmicrovilli located apically andnuclei present at the
basolateral side of the cells by transmission electron microcopy (TEM)
(Fig. 1E). Melanosomes could also be identiﬁed by TEM. Microscopic in-
spection revealed a conﬂuent pigmented monolayer by the end of the
protocol (Fig. 1F).
Additionally, we characterized the hfRPEmonolayer by atomic force
microscopy (AFM) at days 4, 9, 14 and 35 days. Polarized RPE cells were
measured for ﬁrst time by AFM when growing in a transwell setup
(Fig. 1G). During the maturation period, a typical epithelial pattern offects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 1. Polarized RPE cell model characterization. (A) Retinal histological sections immunostained against HtrA1 (pink) from a healthy subject (left) and an AMD patient (right). Nuclei
stained with eosin. Yellow arrows indicate RPE cells. Green arrows indicate the BM (B) Differentiation protocol. (C) Panel of genes that by RNA sequencing experienced an increase
along the differentiation time. (D) Representative images of several characteristic RPE markers: Na+K+ ATPase, PEDF, E-cadherin, N-cadherin, claudin 19 and occludin (green); DAPI
(blue); scale bar, 10 μm. (E) Transmission electron micrographs from hfRPE at day 35 of differentiation; scale bar, 5 μm. Asterisks indicate the nucleus (F) Phase contrast image of
hfRPE cells at the end of the differentiation; scale bar, 50 μm. (G) Mechanical characterization along the differentiation at 4, 9, 14 and 35 days in culture. Mean values and ±SD for
nuclei, cytoplasm and cell junctions from three independent experiments. (G′) Representative force-indentation maps at days 4, 9, 14 and 35 of culture; scale bar, 10 μm. See also Fig.
S1. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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tions were the stiffest region, the cytoplasmic area exhibited intermedi-
ate values, and the cell cytoplasm above the nuclear area the softest.WePlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011also found a general decrease in stiffness for all areas as maturation oc-
curred, with the effect being stronger at the junctions than in the other
two regions (Fig. 1G and 1G′) (Shawky and Davidson, 2015).fects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 2. HtrA1 interacts with tubulin. (A) Immunoprecipitation against β-tubulin and
detection of HtrA1 and β-tubulin in lysates obtained from HtrA1 and S328A HtrA1
overexpressing RPE cells. Left, input material in the column. Right, bound fraction. See
also Fig. S2. (B) Western blot gels for HtrA1 and β-tubulin, representative of a single
experiment from cell lysates incubated in increasing concentration of anti-HtrA1
competing antibody. Left, lysate from HtrA1 overexpressing cells. Right, lysate from
S328A overexpressing cells. (C) Mass Spectrometry identiﬁcation of possible HtrA1
interactors by immunocompetition assays. Concentration of HtrA1 and other beta
subunits decay as the antibody competition antibody increases. Orange, lysate from HtrA1
overexpressing cells. Blue, lysate from S328A overexpressing cells. (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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Cellular Models
Through direct comparison between the overexpression of the pro-
teolytically active HtrA1 protein and the enzymatically inactive S328A
variant, which speciﬁcally neutralizes the HtrA1 proteolytic activity
and leaves the rest of the protein unaltered (Hu et al., 1998) we
intended to reveal molecular details of the mechanism by which the
HtrA1 enzymatic activity could lead to intracellular remodeling in RPE
(Fig. S1c, schematic). Moreover, we conﬁrmed that the percentage of
transfected cellswas the same for both conditions supporting thenotion
that any observed phenotypes are speciﬁc to the particular mutation
and independent of the amount of virus transfected into the cells (Fig.
S1c, left graph). Epithelial barrier function was assessed by measuring
transepithelial electrical resistance (TER) revealing no differences be-
tween the HtrA1 and S328A cells (Fig. S1c, right graph). Achievement
of high TER values by the end of the differentiation conﬁrmed the pres-
ence of a tight barrier, characteristic of a healthy polarized epithelium.
To avoid any effects on proliferation, we transfected the RPE cells in
the second week of growth when the monolayer achieved complete
conﬂuence and the cells were already undergoing maturation (Fig.
S1d). After 5 weeks in culture, cells showed increased content of
HtrA1 detected by Western Blotting (WB) at cellular levels but also in
the apical and basolateral media (Fig. S1e). We detected a clear band
at ~50KDa and observed auto-catalytic events, identiﬁed as bands of
lowermolecularweight, in cells andmedia from theHtrA1 overexpress-
ing condition (Hu et al., 1998).We also observed a higher band ~80 kDa,
which could represent a protein aggregate, since it is known that HtrA1
can form multimers (Eigenbrot et al., 2012). Taken together, these data
show that our hfRPEmodel exhibits mechanical, molecular and expres-
sion/miRNA characteristics associated with a polarized adult-like RPE
phenotype. Hence, this model constitutes a powerful tool to investigate
the consequences induced by HtrA1 pathological overexpression by di-
rect comparison between the proteolytic active HtrA1 protein and the
enzymatically inactive S328A variant.
3.4. HtrA1 Interacts Biochemically with Tubulin in Polarized hfRPE Cells
Leading to a Decrease in the Intracellular Tubulin Content
To conﬁrm the intracellular interaction between HtrA1 andmicrotu-
bules (MT) as reported in previous studies (Chien et al., 2009b) we per-
formed an immunoprecipitation (IP) using a beta-tubulin antibody in
cell lysates from polarized hfRPE overexpressingHtra1 or S328A variant
(Figs. 2A and S2a). We observed the co-immunoprecipitation (coIP) of
HtrA1 irrespectively of the transfection conditions. Accordingly, beta
tubulin was found to be co-immunoprecipitated when using an HtrA1
antibody for pull-down (Fig. 2B). Furthermore, using an Immuno-
Competitive Capture (ICC) approach (Meistermann et al., 2014), we
could validate the speciﬁcity of this interaction (Fig. 2B) as shown by a
gradual decrease in the capture of beta tubulin upon increasing concen-
tration of free competitor antibody. Combined with a mass spectrome-
try (MS) readout and robust statistical analysis, we showed that HtrA1
is interacting speciﬁcally with multiple beta tubulin subunits (Figs. 2C
and S2b) as well as with alpha tubulin and multiple other candidates
(supplemental table S2).
Additionally, we conﬁrmed the cleavage of tubulin by HtrA1 in con-
trol cells by N-terminomics. We treated untransfected RPE cells with
two selective HtrA1 inhibitors Compound RI2404 and Compound
EM3770 which both display single-digit nM HTRA1 inhibition and
selectivity (N40 fold) towards three structurally related serineproteases
of the chymotrypsin family Cathepsin S, Cathepsin G and Neutrophil
Elastase (Fig. S2b). We observed, for both compounds, a more than
two-fold down-regulation of three proteolytic cleavage sites in tubulin,
each of which featured a hydrophobic P1 residue, in-linewith biochem-
ical HtrA1 speciﬁcity (Chien et al., 2009a; Truebestein et al., 2011)
(Fig. S2c and Supplemental table S3).Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011Summarizing these results, we validate the interaction between
HtrA1 and tubulin with high emphasis on the β subunits. In addition,
we provide evidence of tubulin cleavage by HtrA1. These data indicate
a probable role for HtrA1 as a microtubule associated protein (MAP)
and its potential to regulateMT, tubulin stability andMT-associated cel-
lular functions by reducing the amount of tubulin when active and
expressed in high amounts.
Having conﬁrmed the biochemical interaction of HtrA1with tubulin,
we conducted an extensive cellular phenotyping to investigate the ef-
fect of HtrA1 enzymatic activity as well as its intracellular localization
(control cells are in Fig. S3a). To this end, we performed immunostain-
ing assays against HtrA1 in overexpressing RPE cells and foundHtrA1 in
the cytoplasm, below the primary cilium (Fig. S3b), and at the cell-cellfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 3.HtrA1 overexpression associates with tubulin loss and localization at the adherens junctions. (A) IF representative confocal image of S328A (left) and HtrA1 (right) overexpressing
RPE at day 35 of culture. β-tubulin (red), HtrA1 (cyan) and DAPI (blue); scale bar, 10 μm. (A’) β-tubulin intensity quantiﬁcation in HtrA1 positive cells at day 35 of culture. Data represent
themean±SDof three independent experiments, ***p b 0.001. (B) IF high-resolution confocal images (xy plane) of tubulin, claudin-19 and E-cadherin (red) andHrA1 (cyan), DAPI (blue).
The apical membrane faces the top. Yellow arrows indicate cells containing less tubulin.White arrows indicate localization of HtrA1 under claudin-19 and co-localization of HtrA1 and E-
cadherin. Scale bar, 5 μm. (C) Transmission electronmicrographs from immune-gold detection of HtrA1 in S328A, left panel, andHtrA1 overexpressing cells, right panel. Scale bars, 500 nm
and 200 nm. Red arrows indicate gold localization. Dashed line indicates the limit between cells. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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Next, we deconvolved high resolution images and plotted the cross-sec-
tions of polarized RPEs. We could observe HtrA1 localized beneath
Claudin-19 and at the level of E-Cadherin, suggesting that HtrA1
might be conﬁned at the level of adherens junctions but not tight junc-
tions (white arrows in Fig. 3B, Fig. S3c for an apical and basal view). Fur-
ther immunodetection with gold particles conﬁrmed deposition at cell-
cell junctions for both HtrA1 and the S328A variant (Figs. 3C and S3d).
We noticed that RPE transfected with HtrA1 partially lost their typ-
ical microtubule distribution while S328A overexpressing cells contin-
ued to have this cytoskeletal structure (Fig. 3A). When comparing the
tubulin intensity of the S328A versus HtrA1 positive cells, we detected
an intensity reduction of greater than two-fold in the cells expressing
the active protease (p b 0.001; Fig. 3A′).
Moreover, as an internal control, we observed the presence of tubu-
lin at the cytoplasm in neighboring non-transfected cells. Very similar
ﬁndings were reported in OV202 cells (human ovarian carcinoma cell
line resistant to cisplatin) but with α-tubulin staining (Chien et al.,
2009a). Images from the same samples acquired at high resolution
and subsequently deconvolved, conﬁrmed this observation (Fig. 3B). In-
deed, we observed a homogeneous apical tubulin staining in the S328A
overexpressing RPEs. In contrast, HtrA1 overexpressing cells lost
partially the staining in the apical side (yellow arrows in Fig. 3B).Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.0113.5. The Overexpression of HtrA1 Alters the Nanomechanical Properties of
RPEs
In order to examine the contribution of the HtrA1 overexpression to
the mechanical response in living RPE cells, we used an AFM setup with
integrated light microscopy features allowing the AFM tip to be posi-
tioned to scan a deﬁned area of interest. An essential feature of the com-
bined microscope is the option of epiﬂuorescence (Fig. 4A and B), which
allows the overlay of corresponding ﬂuorescence and bright ﬁeld images,
as well as their direct correlation with AFM stiffness maps. To speciﬁcally
address the role of the HtrA1 in cellular elasticity, we have ﬂuorescently
labelled living cells with HtrA1 wild type and variant (S328A) constructs
and examined their effects on the endogenous microtubule network and
stiffness response. Quantitative analysis of the stiffness data (Fig. 4C) has
revealed that enzymatically inactive S328A variant does not inﬂuence the
nanomechanical response of cells while the overexpression of HtrA1 lead
to 2-fold decrease in stiffness, impacting the organization of the endoge-
nous tubulin cytoskeleton system (Fig. 4D).
3.6. HtrA1 Overexpression Translates into Reduced Apical Processes
To further investigate the repercussions of the partial tubulin deﬁ-
ciency,we hypothesized that other functionswhere tubulin is implicatedfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 4. The nanomechanicalﬁngerprint of RPE cells overexpressingHrA1 and S328A variant. (A/B, left panels) The cell viability and position of theAFMprobe ismonitored in the brightﬁeld
signal for each experiment. Live-Fluorescence imaging allowed for identifying the overexpressing cells (white insert). AFM topography and stiffness data belonging to themeasurements
(white insert). (A, right panel) Stiffness data, S328A variant cells exhibit similar properties when compared to the neighboring negative cells. (B, right panel) Stiffness data, HtrA1
overexpressing cells showed a 2-fold decrease for RPEs overexpressing HtrA1 (red line) when compared to cells having a low HtrA1 content (green line). (C) Quantitative stiffness
analysis over multiple measurements. N= 9maps (n= 92 cells) for S328A and N= 17 maps (n= 168 cells) for HtrA1, *p b 0.05. (D) Live cell imaging Halotag TMR ligand for HtrA1
(red), SiR-Tubulin (green) and Hoechst (blue). Scale bar, 20 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to theweb version of this article.)
10 E. Melo et al. / EBioMedicine xxx (2017) xxx–xxxcould also be affected by HtrA1 overexpression. Aside from its role as a
major cytoskeletal component, tubulin is also involved in the formation
of the primary cilium found in RPE cells (Sloboda and Rosenbaum,
2007). In order to induce ciliogenesis, cells were grown without FBS in
the apical compartment of the transwells (Tsang et al., 2008).
To our surprise, when staining RPE cells for β-tubulin, we observed a
distinct epithelial RPE population within the monolayer (Figs. S4c and
S4b). Most cells had a primary cilium but some cells also appeared to
have several cilia protruding from the surface (Fig. 5A). In addition,
staining of RPE cells with α-acetylated tubulin, an appropriate marker
of cilia, has conﬁrmed the presence of multicilation and its co-localiza-
tion with β-tubulin (Fig. S4a). These cells could also be observedPlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011when rendering the images of the stacks (Fig. S4b) or by Scanning Elec-
tronmicroscopy (SEM) (Fig. S4c). This result is intriguing, given the fact
that RPE cells are not known to havemulticiliation events. Interestingly,
the cells that had been grownoverexpressing S328AHtrA1 (Fig. 5A) had
a higher proportion of these distinct, ciliated, RPE cells (8.45% ± 2.77%)
than those that overexpress theWT HtrA1 (1.96%± 0.98%). Differences
between these two populations (Fig. 5A’) were found to be statistically
signiﬁcant (p b 0.001). Control cells grownwith the empty vector had a
similar population as the S328A cells (8.96%±1.9%).When growing the
RPE cells without any viral transduction we did not detect any ciliated
cells, suggesting that the viral transduction could be the trigger for
this response. Naturally occurring or indirectly induced, healthy RPEfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 5.HtrA1 overexpression leads to apical impairment. (A) IF confocal images of RPE at day 35 of culture. β-tubulin (red) and DAPI (blue). Left image, S328A overexpressing cells; right
image, HtrA1 overexpressing cells. Scale bar, 50 μm. Close up images show ciliated cells. (A′) % of ciliated cells in the RPE population. Data represent the mean ± SD of three independent
experiments, ***p b 0.001. See also Fig. S3. (B) Life cell imaging of RPE cells at day 35of culture. Left, S328Aoverexpressing RPE; right, HtrA1 overexpressing RPE. The apicalmembrane faces
the top. Scale bar, 10 μm. (C) Transmission Electronmicrographs of S328A (above) andHtra1 (below) overexpressing cells. Scale bar, 5 μm. (C′)Microvilli per μmof apical membrane. Data
represent the mean ± SD of one experiment, ***p b 0.001. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
11E. Melo et al. / EBioMedicine xxx (2017) xxx–xxxcells are capable of developing cilia (S328A and EV) but not diseased
RPE cells overexpressing the active protease (HtrA1).
Since the transduction vector expressed a GFP reporter cassette,
we could image the RPE monolayer with a dip-in water lens that
allowed us to image the surface of live RPE cells (Fig. 5B). Again, wePlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011could see a drastic difference between the apical processes (microvilli
or cilia) found in the RPE from S328A cells as compared to the HtrA1.
When the active protease was overexpressed we could barely detect
any apical processes and cells appeared ﬂatter compared to the S328A
condition.fects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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tween HtrA1 and S328A cells, the apical microvilli were quantiﬁed by
TEM (Fig. 5C). A signiﬁcant difference (p b 0.001) was found between
cells overexpressing HtrA1 and S328A (Fig. 5C’). The examination by
Scanning Electron Microscopy (SEM) (Fig. S3d) allowed us to compare
the surface of the cells from a different perspective. Furthermore, we
observed that S328A overexpressing cells had a rugose surface that
was not found in HtrA1 overexpressing cells (Fig. S4d).
3.7. HtrA1 Overexpression Leads to Impaired Phagocytic Activity
RPE cells are physically in contact with photoreceptor cells and can
engulf the outer segments (Marmorstein et al., 1998). Therefore, weFig. 6. HtrA1 overexpression is accompanied by a decrease in the phagocytosis activity. (A) Re
treated with Cytochalasyn D, overexpressing S328A cells and HtrA1 overexpressing cells. Zym
to control cells) from S328A overexpressing cells, HtrA1 overexpressing cells and control ce
experiments, ***p b 0.001. (B) Life cell imaging of RPE cells while the process of phagocyto
(green) and Hoechst (blue). Scale bar, 20 μm. (C) Close up image of S328A cells in the momen
phagocyting GFP cells. Mean ± SD of two independent experiments, ***p b 0.001. (For interpr
version of this article.)
Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011hypothesized that diminished apical projections on RPE cells could
lead to an impaired phagocytic activity. To assess for phagocytic perfor-
mance, we challenged the RPE cells with synthetic particles (Fig. 6A)
and further veriﬁed the results with labelled porcine outer segments
(POS) (Fig. 6B–D). After incubation of RPE with opsonized Zymosan A,
we observed that cells transfected with S328A variant had a reduced
phagocytic function compared to the control cells (63.58% ± 19.49 of
control) suggesting a possible effect from the transduction (Fig. 6A′).
However, HtrA1 infected cells exhibited a more prominent reduction:
22.05% ± 14.5 compared to the S328A and control cells (p b 0.0001).
This decrease was similar to that found in the control cells treated
with Cytochalasin D (24.61% ± 15.94), a compound known to inhibit
cell phagocytosis activity. Conﬁrmation of these results was performedpresentative confocal images of Zymosan A treated hfRPE from control cells, control cells
osan A particles (red) and Hoechst (blue). Scale bar, 10 μm (A′) Phagocytic activity (in %
lls treated with Cytochalasyn D at day 35 of culture. Mean ± SD of three independent
sis. Left, S328A overexpressing cells; right, HtrA1 overexpressing cells. POS (red), GFP
t of particle uptake. POS (red), GFP (green) and Hoechst (blue). Scale bar, 10 μm (D) % of
etation of the references to colour in this ﬁgure legend, the reader is referred to the web
fects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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of the S328A and HtrA1 transfected cells (GFP positive) for POS uptake.
The S328A GFP+ population reached a phagocytic activity of 21.27% ±
11.41 compared to only 9.66% ± 6.8 observed in the cells overexpress-
ing HtrA1 (Fig. 5D). This constitutes a statistically signiﬁcant difference
in phagocytosis activity between S328A and HtrA1 cells (p b 0.0001).
Upright imaging of the RPE monolayer during POS incubation
allowed us to identify living cells engulﬁng particles. As predicted, we
found POS particles in those cells with long processes (Fig. 6C). By plot-
ting the images in 3D, we once again conﬁrmed that HtrA1 cells had a
smoother surface with fewer projections, as compared to S328A cells
(Fig. 6B). Also, we found POS binding preferably to non-transfected
HtrA1 GFP- cells (white arrows in Fig. 6B, right panel), which did not
occur in S328A transfected cells where POS were found in the surface
of both GFP+ and GFP- cells (white arrows in Fig. 6B, left panel).
Nevertheless, for quantiﬁcation purposes (Fig. 6A′ and D), only those
cells containing POS internalized were considered. To this end, cells
were examined through the orthogonal projections ensuring that only
those particles reaching the cytoplasm were considered (Fig. S5).
3.8. HtrA1 Aggregates and Degrades Microtubules in vitro
Previous studies have suggested a possible role for HtrA1 in stabiliz-
ing MT in addition to HtrA1 driven tubulin degradation that has been
observed in vitro (Chien et al., 2009b). Our observations in RPE cells sup-
port the idea of HtrA1 degrading tubulinwhilst also having a strong sta-
bilizing effect. Since previous studies were conducted with tubulin
monomers, we decided to perform experiments with polymerized MT
where the protease would be in contact with the ﬁlament instead of
the monomers, allowing us to assess if the same behavior occurred.
To this end, we incubated ﬂuorescently labelled MT (16.7 μg/mL)
with HtrA1 and S328A recombinant proteins (10 μg/mL) over 24 h
and acquired images throughout the digestion. Just 5min after the addi-
tion of the protease, a very strong aggregative effect was observed in
both HtrA1 and S328A (Figs. 7A and S6a). After 6 h, aggregate formation
was detected in the samples incubated with S328A andMT appeared to
be longer. Aggregate formation was also seen in MT incubated with
HtrA1 but, in contrast to S328A, no increase in length was seen. In the
control without HtrA1 or S328A, the MT depolymerized, as the GTP
was consumed, and a reduction in the number of MT present in the so-
lution was observed. The lack of microtubule depolymerization ob-
served in both the HtrA1 and S328A samples indicates that HtrA1 has
a ﬁrst stabilization effect onMT that is not dependent on protease activ-
ity. Interestingly, over time, MT incubated with HtrA1 began to show
signs of degradation including retraction and condensation with the
formation of thick aggregates. After 24 h, HtrA1 incubated samples
contained no MT but, instead, clusters of digested tubulin. In contrast,
at the end of the incubation no signs of microtubule degradation were
observed in the S328A samples.
In order to quantify the events described, we measured the surface
occupied by the MT at time points referred to above (Fig. 7B). Images
were analyzed for the recognition of tube-like structures.We then clus-
tered the distribution of the events in three different groups: long (N 3.5
μm2),medium(0.75–3.25 μm2) and small (shorter than 0.75 μm2). This
analysis allowedus to see that samples incubatedwith the S328A prote-
ase had a similar pattern throughout the incubation time: 57.5–60.5%
short MT, 33–36% medium sized MT, 6–8% long MT. When analyzing
the MT that had been incubated with the HtrA1 protease, we observed
an increase in the proportion of short MT (68.6% at 5 min, 66.7% at 6 h
and 90.5% at 24 h), which is most likely due to degradation. In parallel,
we observed a decrease in the proportion of medium (28.3% at 5 min,
29.7% at 6 h and 9.1% at 24 h) and long MT (3% at 5 min, 3.6% at 6 h
and 0.3% at 24 h).
We alsowish to emphasize that the difference in length between the
MT incubated with HtrA1 and S328A protease were at all times present,
having always a bigger proportion of long and medium size MT in thePlease cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011S328A samples as compared with the HtrA1 incubated MT. When
performing a Mann-Whitney non-parametric test to compare the two
groups, at the measured times, we obtained statistically signiﬁcant dif-
ferences (p b 0.001). Thus, diverse results can be read from this experi-
ment: HtrA1 and S328A can stabilize MT and aggregate them in a ﬁrst
moment, with a stronger effect observed in S328A. Only MT incubated
with HtrA1 are degraded over the time.
3.9. HtrA1 Impairs Microtubule Polymerization
Since formation of cilia requires polymerization of tubulin de novo,
we decided to investigate if HtrA1would have any effect on this process
in vitro. Previous experiments reported that HtrA1 promotes the assem-
bly and stability of the MT at low concentrations (15 ng/mL) but not at
high concentrations (1.5 μg/mL) (Chien et al., 2009b). Based on our ob-
servations we found that S328A overexpressing cells formed new cilia
but not HtrA1 cells. To ﬁt with this result, we would expect HtrA1 and
S328A to be present at high concentrations in the cytoplasm of the
RPE cells. Therefore, we decided to perform our experiments at tubulin
concentrations of 3 mg/mL with HtrA1 at 10 μg/mL. To maximize the
interaction of the tubulin subunits with the recombinant proteins, we
incubated the solutions at 4 °C for 30min and then started the polymer-
ization at 37 °C. As a control, we performed the experiments with and
w/o taxol (MT stabilizer) for all conditions.
As shown in Fig. 7C/C′, when polymerizing the MT all conditions
reached a plateau after around 60 min. Through comparison of the ex-
periments performed with and w/o taxol, we can see that the effects
are stronger in the presence of this compound (Fig. S6b). Samples incu-
bated with S328A achieved the highest signals, whereas samples poly-
merizing in the presence of HtrA1 achieved the lowest (Figs. 7D and
S6c, top). Signal values directly report the quantity ofMT formed,mean-
ing that S328A lead to the formation of more MT than the other two
conditions (p b 0.001). The ﬁlament formation rate constant was iden-
tical within error between control and S328A polymerized samples, im-
plying that S328A affects the amount of MT generated but not the
polymerization kinetics (Figs. 7E and S6c, middle). MT polymerized
with HtrA1 were signiﬁcantly lower in quantity and also slower in
their formation compared to S328A incubated (p b 0.01) or control (p
b 0.05). Thus, HtrA1 appears to have an effect at both levels: quantity
of MT formed and the speed at which they grow. Finally, assessment
of the time at which enucleation started (lag time), revealed a marked
difference between the conditions: S328A was the fastest to enucleate
and HtrA1 the slowest. Statistically signiﬁcant differences were found
between the HtrA1 incubated samples and the other two conditions
(p b 0.05) (Figs. 7F and S6c, bottom).
4. Discussion
The growing evidence indicates that HtrA1 plays an important role
in AMD pathophysiology however no treatment has been developed
to target this protease. The lack of therapies can be partially attributed
to the limited understandingwe have of AMD and, in particular, the ab-
sence of reliable cellular models. In this work, we introduce a polarized
and physiologically relevant RPE cell-culture model system where the
impact of HtrA1 overexpression on cellular phenotype and functions
could be evaluated. Intracellular HtrA1 interactomics studies allowed
us to identify several HtrA1 binding partners with a large proportion
of candidates emerging from the tubulin protein family. By mimicking
the disease with a native and enzymatically inactive S328A variant we
have been able to compare their phenotypes and understand the effect
of the intracellular increase in HtrA1 at a functional level. Overexpres-
sion of the active protease leads to apical dysfunction accompanied by
decreased phagocytic activity, one of the most pivotal functions of
polarized RPE cells.
We cultured highly differentiated human RPE cells by developing a
3-step protocol and provided several lines of evidence to show thatfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
Fig. 7. HtrA1 degrades preformed MT and avoids polymerization in vitro. (A) MT polymerized in vitro and incubated with S328A HtrA1 (center) and HtrA1 (right). Images acquired at
5 min, 6 h and 24 h after adding the protease. Scale bar, 10 μm. (B) Quantiﬁcation of the area occupied by the MT 5 min, 6 h and 24 h after adding the protease. (C) Microtubule
polymerization reactions in the absence or presence of S328A HtrA1 and HtrA1. As a representative growth signal, the absorbance at 340 nm was monitored in vitro as a function of
time for three independent replicates. (C′) The average growth signal for each variant was calculated and normalized relative to the overall maximum. Best ﬁts to sigmoidal function
are shown with solid lines. (D) Comparison of the growth amplitudes (Srel), (E) kinetic rate constants (kF), (F) nucleation time (tlag) of microtubule polymerization reaction in the
absence or presence of S328A HtrA1 and HtrA1. Mean ± SD for three replicates are reported, *p b 0.05, **p b 0.01, ***p b 0.001.
14 E. Melo et al. / EBioMedicine xxx (2017) xxx–xxxthe RPE cells matured towards the desired phenotype. Immunocyto-
chemical characterization of tight/adherens junctions and TEM imaging
conﬁrmed a proper polarization of the cells. Moreover, by mRNA and
miRNA proﬁling we described a typical RPE signature. Furthermore, we
were been able to identify seven miRNA that were also described in the
literature in human (Li et al., 2012; Wang et al., 2014) or mice RPE cells
(Ohana et al., 2015; Soundara Pandi et al., 2013) from tissue or cell culture
origin. Nevertheless, our work is the ﬁrst to generate such proﬁles
employing differentiated RPE cells from human fetal origin.Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011The mechanical characterization performed with AFM is also a nov-
elty in the ﬁeld. To date, the majority of mechanical measurements by
AFM have been performed on cell lines (Haase and Pelling, 2015). We
report, for ﬁrst time, results acquired on primary epithelial cells that
were cultured on transwell inserts. Mechanical measurements using a
nanometer scale AFM force measurements have revealed a characteris-
tic mechanical hallmark of healthy epithelia (Plodinec et al., 2012) with
cell-cell junctions being predominantly stiffer than the cytoplasm or the
perinuclear area. Moreover, we demonstrated that RPE cells softenfects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
15E. Melo et al. / EBioMedicine xxx (2017) xxx–xxxduring the differentiation protocol and especially at the junctional level.
This time-lapse characterization was essential to obtain the baseline
mechanical properties of RPE since we hypothesized that any effect of
HtrA1 involving adhesion or cytoskeleton components would presum-
ably affect their mechanical features.
There is a limited knowledge of the role HtrA1 might play at the
cellular level by affecting various RPE functions. Chien et al. identiﬁed
intracellular proteins that could be potential substrates of HtrA1 by de-
termining cleavage site motifs usingmixture-based oriented peptide li-
brary screening, and identiﬁed tubulins as potential intracellular
substrates (Chien et al., 2009a). In this work and in a further study,
they validated the idea that HtrA1 is a MAP and observed an inhibition
in the migration of the cells (Chien et al., 2009b).
However, these ﬁndings do not seem to translate to RPE cells.
Indeed, Pei and colleagues reported inhibition of proliferation and
migration after HTRA1 knockdown in ARPE19 cells (Pei et al., 2015).
Ultimately, the response of RPE could be different to that in SKOV3
(estrogen positive human ovarian carcinoma cell line) and OV202
cells, since they have a completely different origin and role. In addition,
primary RPE differ from the ARPE19 cell line, which although revealing
some polarization features does not completely display certain key
characteristics, such a high TEER (Dunn et al., 1996). In addition, the
role of HtrA1 in any of the key functions performed by RPE, such as
phagocytosis, has never been explored.
To this end, we sought to recapitulate the increase in HtrA1 tran-
scriptional levels, which have been associated with disease predisposi-
tion and pathogenesis. We found the use of an adenovirus-mediated
overexpression more suitable to overcome the primary cells intrinsic
variability, resulting in a stable and reproducible approach.
As suggested by Chien et al. we conﬁrmed that overexpression of
proteolytic active HtrA1 contributed to tubulin degradation and micro-
tubule loss also in RPE cells. In contrast, we did not observe such a
phenotype for the S328A variant, indicating more speciﬁcally that the
activity of HtrA1 is responsible for tubulin degradation. HtrA1 interac-
tome analysis reinforced the idea that a strong interaction occurs
between HtrA1 and several α and β tubulin subunits. We could also
conﬁrm the cleavage of tubulin by HtrA1 in non-overexpressing cells
using a TAILS proteomics approaches in conjunction with a small mole-
cule inhibitor of HtrA1, indicating that HtrA1 also regulates tubulin in
baseline conditions. Interestingly among the other interacting candi-
dates and new to the ﬁeld, we have found Complement C1q tumor
necrosis factor-related protein 5 (C1QTNF5) as speciﬁcally interacting
with HtrA1. C1QTNF5 is described as a component of basement
membranes that may play a role in cell adhesion. More interestingly,
mutations in this gene have been associated with late-onset retinal de-
generation (Shu et al., 2006). Future studies are necessary to elucidate
the implications of other HtrA1 cleaved products such as C1QTNF5
and other interacting candidates.
Microtubules are important in many cellular functions, including
cell division, shape integration, force transduction and vesicle trans-
port. In case of differentiated RPE, where no divisions are occurring
and little migration is expected, the most probable functions that
could be affected by tubulin dysfunction would be those concerning
themechanical structuremaintenance(Schaedel et al., 2015) and specif-
ic processes from RPE where an active participation of the cytoskeleton
is crucial, such as the phagocytosis of the OS (Ruggiero and Finnemann,
2014).
Thus, we assessed the phagocytic function and observed that cells
overexpressing HtrA1 showed diminished phagocytic activity, which
could be further conﬁrmed with OS. In the light of these results, it
would be reasonable to expect the photoreceptors to suffer from the ac-
cumulation of OS, which would not be properly engulfed, eventually
compromising the survival of these cells, a typical pathological pheno-
type of AMD. Indeed, impairment of phagocytosis and renewal of POS
induce retina degeneration resembling AMD like phenotypes, as report-
ed in knockout mice such as ATP-binding cassette transporter 4Please cite this article as: Melo, E., et al., HtrA1 Mediated Intracellular Ef
(2017), https://doi.org/10.1016/j.ebiom.2017.12.011(ABCA4) or alphavbeta5 integrin (Nandrot et al., 2004; Radu et al.,
2004).
In the retina, microvilli of the RPE apical membrane interdigitate
with the OS of the photoreceptors (Marmorstein et al., 1998). Absence
of microvilli was revealed by apical imaging of RPE cells overexpressing
active HtrA1 but not when the S328Awas overexpressed. It is tempting
to speculate that this apical dysfunction could be the reason behind the
diminished phagocytic activity of the diseased cells. This speculation is
consistent with the observation that cells having the longest apical pro-
cesses were the ﬁrst among the population to uptake the outer segment
particles. How the protease could be affecting the apical processes is still
a question to be answered, since themicrovilli are composed of actin ﬁl-
aments. Further investigation would need to be done to explore the re-
lationship between the actin compartment of the cytoskeleton and the
rearrangements occurring when tubulin is degraded.
Microtubules have a signiﬁcant contribution to cell stiffness in
cells and hence, its disruption could cause a decrease in cell stiffness
(Stamenovic, 2005). In line with this, we demonstrated that RPE cells
overexpressing HtrA1 exhibited a signiﬁcant decrease in tubulin
content which translated into a modiﬁcation in the cellular stiffness
(Fig. 4A). As previously reported, rearrangements in the microtubule
component of the cytoskeleton and melanosomes have been associ-
ated with cell softening in RPE (Sarna et al., 2016). Notably, we also
observed that RPE cells overexpressing HtrA1 appeared to be less
pigmented than the S328A ones (data not shown). In line with
that, a recent study reported a reduction in the RPE melanosomes
in AMD patients suggesting that age-related changes of RPE melano-
somes may correlate with the development of this disease (Booij et
al., 2010).
Additional evidence comes from observations made at the cellular
junctions. For example, we observed clear deposition of the HtrA1 at
the adherens junctions and not at the tight junctions as indicated by
the prominent staining below Claudin19 and co-localization with E-
cadherin. Taken together; major decrease in RPE stiffness associated
with increased tubulin degradation and co-localization of HtrA1 with
E-cadherin at the adherens junctions provides a plausible explanation
for the loss of adhesion in the RPE cells but not the lack of barrier func-
tion. Indeed, computational models of AMD, suggested that defects in
the adhesion dominate the neovascularization initiation and progres-
sion (Shirinifard et al., 2012). The physical and mechanical barrier that
in physiological conditions confers resistance to the vessels would, in
a pathological milieu, allow for the choroid to trespass to the neural ret-
ina (Dugel and Zimmer, 2016). Future studies are necessary to identify
the exact interactors at the cell-cell junction level and to further inves-
tigate the mechano-functional relationship between HtrA1 and the
RPE adhesion loss.
Chien et al., suggest that at low concentrations, the protease pro-
motes higher steady-state levels of tubulin polymerization in vitro. At
high concentrations, on the other hand, HtrA1 would have the opposite
effect and reduce tubulin polymerization. However, these data were
produced by polymerizing the MT at 25 °C, and the behavior of HtrA1
would not necessarily be the same at 37 °C. In addition, Chien et al.
did not investigate the role of the S328A variant or the role of a full-
length HtrA1.
Our results, obtained physiological conditions, show a very clear dif-
ference between HtrA1 and S328A. HtrA1 disrupted the formation of
MT, whilst the mutant S328A conferred stability to the polymers and
enhanced microtubule levels to above those of the control tubulin. MT
polymerized in the presence of the active HtrA1 had a lower growth
rate and the time needed for enucleation was substantially longer.
This delay could possibly be explained by the concomitant degradation
occurring as theMT are forming. It is also remarkable, that we could ob-
serve an ampliﬁcation of the described patterns when the experiments
were performed with taxol, where it was observed that the stabilizing
agentwas additive to the effects of S328A but could not rescue the activ-
ity of HtrA1.fects on Tubulin Using a Polarized RPE Disease Model, EBioMedicine
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dition, we hypothesized that two distinct events could be occurring.
Either more MTs were being formed or the MTs formed in presence of
the S328A HtrA1 were longer. In this regard, the experiments where
we polymerized the MT ﬁrst and then added the protease afterwards
(Fig. 7A and B) would be providing an answer. In the presence of the
S328A protease, the MTs were aggregating becoming longer than the
control ones. It is reasonable to think, that MTs polymerized in the pres-
ence of S328A also became longer and this lead to the higher amount
quantiﬁed after 120 min of polymerization.
Taken together, it seems that the S328A variant has a stabilizing
effect that could be observed both in the polymerization of new MT
as well as in those already polymerized. The active protease
HtrA1 seems to behave differently. When HtrA1 is incubated with
preformed MT, it appears to ﬁrst aggregate and slightly stabilize
MTs and then degrade them (as seen after 24 h). During polymeriza-
tion, the stabilization by HtrA1 does not occur and only degradation
takes place. Therefore, there could be a double role: one of stabiliza-
tion and one of degradation. The stabilizing effect seems to be an in-
trinsic function of the HtrA1 protein unrelated to its proteolytic
activity when the MTs are already formed. In contrast, the degrada-
tion role seems to be speciﬁc and mediated by the enzymatic active
HtrA1 on either growing or already formed MT, provided the prote-
ase is present in high concentrations.
This dualistic nature of HtrA1 observed in vitrowould clarifywhywe
are able to ﬁndMT in the S328A overexpressing cells, which fade in the
HtrA1 condition. It could explain also the observation of higher frequen-
cy of multiciliation events in the S328A variant. Indeed, for this latest
process polymerization of tubulin de novo is necessary and RPE cells
overexpressing HtrA1 would not be able to achieve this step, clarifying
the lack of mutliciliated events in such condition.
In conclusion, we have established a polarized RPE cell culture
model that enables exploration of the functional consequences of path-
ological HtrA1 increase observed in human retinas form AMD patients.
Overexpression of HtrA1 has revealed a diminished content of tubulin
along with a prominent decrease in cell stiffness and dysfunction in
the apical processes of the RPE cells. This disease phenotype translates
into altered mechanical stability of the retinal layer and impaired
phagocytosis activity. We have elucidated the molecular mechanisms
by which the HtrA1 enzymatic activity affects either the intracellular
degradation or polymerization of tubulin and consequently alters the
RPE mechanics. Taken together our cell culture model provides an es-
sential platform to investigate functional role of HtrA1 in RPE cells
with signiﬁcant implications for developing therapeutic interventions
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